SPEECH-PROCESSING-SOLU
21.6.2016 09:03:13 CEST | Business Wire | Press release
Speech Processing Solutions , the international leader in professional dictation, just launched a new dictation microphone. The improved SpeechMike Premium Touch comes with an innovative touch sensor for optimized and ergonomic navigation, including reduced thumb movement, and an enhanced barcode scanner for quick and easy file association. In addition to these user-friendly updates, the device can scan even more types of bar- and QR codes than its predecessor. The SpeechMike Premium Touch dictation microphone lets healthcare, legal and business professionals dictate their documents, saving them time and resources by allowing them to accomplish their core tasks – benefits that can be directly passed on to their clients.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160621005179/en/
Renowned for its superior microphone quality
The Philips SpeechMike Premium has long been known for its crystal-clear recording quality, and sets the standard for dictation devices worldwide. The free-floating microphone guarantees that almost no background, touch, click, air or structure-borne noise is recorded. “The SpeechMike Premium has established itself as THE benchmark for professional dictation microphones in the industry,” said Dr. Thomas Brauner, CEO of Speech Processing Solutions. “Unrivaled recording quality and noise canceling capabilities, as well as its perfect ergonomics and the antimicrobial surface make it a perfect tool for professional dictation users. These functions are especially helpful for attorneys and medical personnel.”
Focus on content
The new device is equipped with a durable touch sensor. Users can accurately control their mouse cursor using the new SpeechMike Premium Touch. This allows them to easily use and navigate within applications while recording, without having to switch between the mouse and microphone .
Less frequently used functions are placed above or below the sensor, and clearly delineated. Clearly marked distances and different shapes are perfect for operating the device without constantly looking down. Even the Premium Touch’s flip side is optimized for ergonomic and easy use: “Trigger” and “Command” buttons are placed just right to prevent unwanted activation. The key is to focus on content rather than complicated usage instructions. Configurable functions permit a personalized workflow, and an integrated movement sensor that mutes the microphone when not in use adds a finishing touch. “The new features guarantee smooth and convenient operation, even when recording over longer periods of time every day. The Premium Touch can also read more barcodes than its predecessor, allowing end users to quickly categorize and associate client and patient data. The results are enhanced security and potential cost savings,” said Brauner.
Speech to text made easy
Philips SpeechMike Premium Touch makes going from recording your voice to a written document a simple process. The dictation microphone is easy to integrate into users’ IT infrastructures, and works in harmony with existing software, both in large hospitals or small businesses. Thanks to the excellent recording quality, Philips SpeechMike Premium Touch is perfectly suited for transcription, whether by an assistant, speech recognition software, or Philips dictation workflow solutions such as SpeechLive and SpeechExec.
Philips SpeechLive dictation solution
Philips workflow software creates a smooth and safe work cycle between authors and transcriptionists. “Philips SpeechLive is a perfect solution for people like myself, who are on the go a lot. It guarantees a reliable and safe transmission of dictations, regardless of what time it is” explained Dr. Peter Klein, partner at the international law firm PFKA, in Austria adding that: “The offered transcription service is another advantage, particularly in foreign languages such as French, as it virtually increases our office’s capacity.”
For more information on the Philips SpeechMike Premium Touch (SMP3700/3800 series) visit: www.philips.com/dictation
Philips is now offering a free 30-day SpeechLive trial including 10 free transcription minutes at: www.speechlive.com
About Speech Processing Solutions
Speech Processing Solutions is the global number one in professional dictation. Founded in Austria in 1954 as part of Philips, the company has been the driving force in speech-to-text innovations for over 60 years. Always striving for excellence and putting emphasis on outstanding quality, the company has designed groundbreaking products, such as the portable Philips Pocket Memo voice recorder , the Philips SpeechMike Premium dictation microphone and the Philips SpeechExec dictation recorder app for smartphones. The latest innovation, Philips SpeechLive , makes dictation quicker and more convenient than ever before, by bringing secure dictation workflow to the cloud and enabling seamless speech-to-text with the new speech recognition service. With solutions perfectly tailored to individual industry needs, Speech Processing Solutions has helped millions of satisfied customers around the globe save time and resources, allowing them to work as efficiently as possible.
Connect with Speech Processing Solutions on:
Facebook: http://www.facebook.com/philipsvoicetracer
Twitter @speech_com: http://www.twitter.com/speech_com
YouTube: http://www.youtube.com/philipsdictation
LinkedIn: http://www.linkedin.com/company/speech-processing-solutions
View source version on businesswire.com: http://www.businesswire.com/news/home/20160621005179/en/
Contact:
Speech Processing Solutions
Lea Pachta
lea.pachta@speech.com
Tel:
+43 1 60529-1744
www.philips.com/dictation
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alsym Energy Announces Na-Series Battery Success Developed With Physics-Informed AI Platform27.4.2026 21:25:00 CEST | Press release
Alsym’s proprietary physics-informed AI platform powered the development of its Na-Series batteries—a non-flammable, high performance and low cost energy solution positioned to serve critical energy storage markets including data centers, utilities, telecommunications, commercial real estate, industrial and defense, among others. Alsym Energy, a pioneer in non-flammable, high-performance sodium-ion batteries, today announced details of the proprietary physics-informed AI platform used to develop the company’s recently launched Na-Series sodium-ion batteries. By integrating fundamental physics models with AI, autonomous testing and proprietary molecular diagnostics in a closed-loop system, Alsym is accelerating the design of safer, inexpensive, commercialized batteries through all phases of the development cycle. As global demand for electricity surges, the limitations of lithium-ion batteries have become increasingly apparent, particularly around safety and supply chain constraints. Li
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 202627.4.2026 15:00:00 CEST | Press release
Premier global event to highlight how organizations are bringing data to life to power everything from AI to BI Boomi, the data activation company, today announced Boomi World 2026, its premier annual user conference, taking place May 11 - 14, 2026 in Chicago, IL. The event will bring together customers, partners, and industry leaders from around the world to explore how data activation is transforming the enterprise and accelerating the path to AI-driven outcomes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427600340/en/ Boomi To Unveil the Future Of Data Activation and AI-Driven Innovation at Boomi World 2026 Boomi World 2026 will spotlight data activation — bringing data to life to power AI, analytics, and intelligent automation. Attendees will gain firsthand insights into how the Boomi Enterprise Platform enables businesses to unify data, streamline operations, and innovate faster in an increasingly agentic world.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
